Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03952091
What this trial is testing

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseRefractory Multiple Myeloma
TJ Biopharma Co., Ltd. 289
Testing effectiveness (Phase 2)Study completedNCT00006013
What this trial is testing

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fox Chase Cancer Center 21
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Early research (Phase 1)Study completedNCT02332850
What this trial is testing

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Thomas Martin, MD 83
Not applicableUnknownNCT06258096
What this trial is testing

LI-TASTE Study: Light for Taste

Who this might be right for
Multiple Myeloma
Academic Centre for Dentistry in Amsterdam 52
Not applicableUnknownNCT03201614
What this trial is testing

Comparative Evaluation of A-CP HA Kit, Hyaluronic Acid and Placebo for the Treatment of Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Regen Lab SA 290
Testing effectiveness (Phase 2)Study completedNCT03240133
What this trial is testing

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
BioCryst Pharmaceuticals 58
Early research (Phase 1)Study completedNCT03007264
What this trial is testing

Cold Plasma for Wound Treatment, Safety Study

Who this might be right for
Intact SkinContaminant Given to Patient
Association of Dutch Burn Centres 25
Not applicableStudy completedNCT03548298
What this trial is testing

Antireflux Ablation Therapy (ARAT) for Gastroesophageal Reflux Treatment

Who this might be right for
Gastro Esophageal Reflux
Coordinación de Investigación en Salud, Mexico 95
Early research (Phase 1)Study completedNCT01871987
What this trial is testing

Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers

Who this might be right for
HealthyPlasma Concentration Change of Quetiapine
Astellas Pharma Inc 24
Not applicableStudy completedNCT05979584
What this trial is testing

Platelet Rich Plasma VS Platelet Fibrin Plasma in Treatment of Diabetes Related Wound：a Randomized Controlled Trial

Who this might be right for
Diabetic Foot
Peking University Third Hospital 56
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Testing effectiveness (Phase 2)Study completedNCT00783367
What this trial is testing

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas

Who this might be right for
Follicular LymphomaMarginal Zone B-Cell LymphomaMALT Lymphoma+4 more
Abramson Cancer Center at Penn Medicine 50
Not applicableStudy completedNCT01524445
What this trial is testing

Retrospective Survey of Re-treatment With Bortezomib

Who this might be right for
Hematological CancerMultiple Myeloma
Janssen Pharmaceutica N.V., Belgium 35
Testing effectiveness (Phase 2)Study completedNCT01720875
What this trial is testing

Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)

Who this might be right for
Multiple Myeloma
University of Leeds 16
Not applicableNo Longer AvailableNCT02368301
What this trial is testing

Expanded Access Treatment Protocol CA204-143

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02316353
What this trial is testing

Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 126
Early research (Phase 1)Study completedNCT05789745
What this trial is testing

Evaluate Plasma Gelsolin in Healthy Volunteers

Who this might be right for
VolunteersHealthy
BioAegis Therapeutics Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT04432272
What this trial is testing

ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections
Corewell Health East 71
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Next Page